A Review on Relationship Between Human Endogenous Retrovirus Groups and Human Diseases
Archives of Medical Laboratory Sciences,
Vol. 4 No. 4 (2018),
16 February 2020
https://doi.org/10.22037/amls.v4i4.25635
Abstract
Various factors are involved in the incidence of some diseases like autoimmune, psychiatric and cancerous ones. One of these probable factors is considered as the endogenous retroviruses, for example, proviruses that have been introduced in previous generations in some organisms' genome, and make up over 8% of the human genome. Recent studies have indicated that these factors and their related products (including RNA, cytosolic DNA, and proteins) may affect and also change the host cell function and immune system. This review summarizes the detailed information about the structure, classification, and pathogenesis mechanism of human endogenous retroviruses and their relationship with the autoimmune diseases and some kinds of cancers.
- Endogenous Retroviruses
- Autoimmune disease
- Mental Disorders
- Neoplasms
How to Cite
References
Hancks DC, Kazazian HH. Roles for retrotransposon insertions in human disease. Mobile DNA. 2016;7(1):9.
Hurst T, Magiorkinis G. Epigenetic control of human endogenous retrovirus expression: focus on regulation of long-terminal repeats (LTRs). Viruses. 2017;9(6):130.
Singh SK. Endogenous retroviruses: suspects in the disease world. 2007.
Belshaw R, Pereira V, Katzourakis A, Talbot G, Pačes J, Burt A, et al. Long-term reinfection of the human genome by endogenous retroviruses. Proceedings of the National Academy of Sciences. 2004;101(14):4894-9.
Nelson PN, Hooley P, Roden D, Davari Ejtehadi H, Rylance P, Warren P, et al. Human endogenous retroviruses: transposable elements with potential? Clinical & Experimental Immunology. 2004;138(1):1-9.
Antony JM, DesLauriers AM, Bhat RK, Ellestad KK, Power C. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2011;1812(2):162-76.
Armbruester V, Sauter M, Krautkraemer E, Meese E, Kleiman A, Best B, et al. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clinical Cancer Research. 2002;8(6):1800-7.
Grandi N, Tramontano E. HERV envelope proteins: physiological role and pathogenic potential in cancer and autoimmunity. Frontiers in microbiology. 2018;9:462.
Büscher K, Hahn S, Hofmann M, Trefzer U, Özel M, Sterry W, et al. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma research. 2006;16(3):223-34.
Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clinical microbiology reviews. 1996;9(1):72-99.
Medstrand P, Blomberg J. Characterization of novel reverse transcriptase encoding human endogenous retroviral sequences similar to type A and type B retroviruses: differential transcription in normal human tissues. Journal of virology. 1993;67(11):6778-87.
Vargiu L, Rodriguez-Tomé P, Sperber GO, Cadeddu M, Grandi N, Blikstad V, et al. Classification and characterization of human endogenous retroviruses; mosaic forms are common. Retrovirology. 2016;13(1):7.
Nelson PN, Carnegie P, Martin J, Ejtehadi HD, Hooley P, Roden D, et al. Demystified... Human endogenous retroviruses. Molecular Pathology. 2003;56(1):11.
Jern P, Sperber GO, Blomberg J. Use of endogenous retroviral sequences (ERVs) and structural markers for retroviral phylogenetic inference and taxonomy. Retrovirology. 2005;2(1):50.
Grandi N, Cadeddu M, Blomberg J, Tramontano E. Contribution of type W human endogenous retroviruses to the human genome: characterization of HERV-W proviral insertions and processed pseudogenes. Retrovirology. 2016;13(1):67.
Grandi N, Tramontano E. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses. Frontiers in immunology. 2018;9:2039.
Jern P, Coffin JM. Effects of retroviruses on host genome function. Annual review of genetics. 2008;42:709-32.
Cohen CJ, Lock WM, Mager DL. Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene. 2009;448(2):105-14.
Christensen T. Human endogenous retroviruses in neurologic disease. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2016;124(1-2):116-26.
Weiss RA. Human endogenous retroviruses: friend or foe? APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2016;124(1-2):4-10.
Young GR, Stoye JP, Kassiotis G. Are human endogenous retroviruses pathogenic? An approach to testing the hypothesis. BioEssays : news and reviews in molecular, cellular and developmental biology. 2013;35(9):794-803.
Young GR, Ploquin MJ, Eksmond U, Wadwa M, Stoye JP, Kassiotis G. Negative selection by an endogenous retrovirus promotes a higher-avidity CD4+ T cell response to retroviral infection. PLoS pathogens. 2012;8(5):e1002709.
Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 1997;90(2):303-13.
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Annals of Neurology. 2001;50(4):434-42.
Christensen T. Human endogenous retroviruses in the aetiology of MS. Acta neurologica Scandinavica. 2017;136 Suppl 201:18-21.
Lewis DA. Retroviruses and the pathogenesis of schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;98(8):4293-4.
Frank O, Giehl M, Zheng C, Hehlmann R, Leib-Mosch C, Seifarth W. Human endogenous retrovirus expression profiles in samples from brains of patients with schizophrenia and bipolar disorders. J Virol. 2005;79(17):10890-901.
McCormick AL, Brown RH, Cudkowicz ME, Al-Chalabi A, Garson JA. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology. 2008;70(4):278.
Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nature immunology. 2014;15(5):415-22.
Br, #xfc, tting C, Emmer A, Kornhuber ME, Staege MS. Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases. BioMed Research International. 2017;2017:11.
Suntsova M, Garazha A, Ivanova A, Kaminsky D, Zhavoronkov A, Buzdin A. Molecular functions of human endogenous retroviruses in health and disease. Cellular and molecular life sciences : CMLS. 2015;72(19):3653-75.
Krishnamurthy J, Rabinovich BA, Mi T, Switzer KC, Olivares S, Maiti SN, et al. Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015;21(14):3241-51.
Grabski DF, Hu Y, Sharma M, Rasmussen SK. Close to the Bedside: A Systematic Review of Endogenous Retroviruses and Their Impact in Oncology. Journal of Surgical Research. 2019;240:145-55.
Schmitt K, Reichrath J, Roesch A, Meese E, Mayer J. Transcriptional profiling of human endogenous retrovirus group HERV-K(HML-2) loci in melanoma. Genome biology and evolution. 2013;5(2):307-28.
Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol. 1997;71(6):4581-8.
Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, et al. Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. International journal of cancer. 2014;134(3):587-95.
Arru G, Leoni S, Pugliatti M, Mei A, Serra C, Delogu LG, et al. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. Multiple sclerosis (Houndmills, Basingstoke, England). 2014;20(2):174-82.
Madeira A, Burgelin I, Perron H, Curtin F, Lang AB, Faucard R. MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment. Journal of neuroimmunology. 2016;291:29-38.
van Horssen J, van der Pol S, Nijland P, Amor S, Perron H. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis. Multiple sclerosis and related disorders. 2016;8:11-8.
Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, et al. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Multiple sclerosis (Houndmills, Basingstoke, England). 2012;18(12):1721-36.
Antony JM, van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nature neuroscience. 2004;7(10):1088-95.
Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. The Journal of general virology. 2007;88(Pt 1):264-74.
Morandi E, Tanasescu R, Tarlinton RE, Constantin-Teodosiu D, Gran B. Do Antiretroviral Drugs Protect From Multiple Sclerosis by Inhibiting Expression of MS-Associated Retrovirus? Frontiers in immunology. 2019;9:3092-.
Arru G, Sechi E, Mariotto S, Farinazzo A, Mancinelli C, Alberti D, et al. Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple sclerosis journal - experimental, translational and clinical. 2017;3(4):2055217317742425-.
Perron H, Lazarini F, Ruprecht K, Pechoux-Longin C, Seilhean D, Sazdovitch V, et al. Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. Journal of neurovirology. 2005;11(1):23-33.
Zawada M, Liwien I, Pernak M, Januszkiewicz-Lewandowska D, Nowicka-Kujawska K, Rembowska J, et al. MSRV pol sequence copy number as a potential marker of multiple sclerosis. Polish journal of pharmacology. 2003;55(5):869-75.
Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, Warren KG, et al. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. Journal of immunology (Baltimore, Md : 1950). 2007;179(2):1210-24.
Nexø BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T, et al. Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci. Immunologic research. 2016;64(1):55-63.
Huang W, Li S, Hu Y, Yu H, Luo F, Zhang Q, et al. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophrenia bulletin. 2011;37(5):988-1000.
Tai AK, O'Reilly EJ, Alroy KA, Simon KC, Munger KL, Huber BT, et al. Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). 2008;14(9):1175-80.
Rasmussen HB, Geny C, Deforges L, Perron H, Tourtelotte W, Heltberg A, et al. Expression of endogenous retroviruses in blood mononuclear cells and brain tissue from multiple sclerosis patients. Multiple Sclerosis Journal. 1995;1(2):82-7.
Christensen T, Dissing Sorensen P, Riemann H, Hansen HJ, Munch M, Haahr S, et al. Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta neurologica Scandinavica. 2000;101(4):229-38.
Bhetariya PJ, Kriesel JD, Fischer KF. Analysis of Human Endogenous Retrovirus Expression in Multiple Sclerosis Plaques. Journal of emerging diseases and virology. 2017;3(2).
Christensen T, Petersen T, Thiel S, Brudek T, Ellermann-Eriksen S, Moller-Larsen A. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. Journal of neuroimmunology. 2007;183(1-2):175-88.
Nissen KK, Laska MJ, Hansen B, Pedersen FS, Nexo BA. No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients. Virology journal. 2012;9:188.
Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, Moller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology. 2009;6:104.
Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, et al. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clinical and experimental immunology. 2010;160(3):340-7.
Seidl C, Donner H, Petershofen E, Usadel KH, Seifried E, Kaltwasser JP, et al. An endogenous retroviral long terminal repeat at the HLA-DQB1 gene locus confers susceptibility to rheumatoid arthritis. Human Immunology. 1999;60(1):63-8.
Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, Mougin B, et al. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scandinavian journal of immunology. 2009;70(3):295-9.
Nelson PN, Lever AM, Smith S, Pitman R, Murray P, Perera SA, et al. Molecular investigations implicate human endogenous retroviruses as mediators of anti-retroviral antibodies in autoimmune rheumatic disease. Immunological investigations. 1999;28(4):277-89.
Nakkuntod J, Sukkapan P, Avihingsanon Y, Mutirangura A, Hirankarn N. DNA methylation of human endogenous retrovirus in systemic lupus erythematosus. Journal of human genetics. 2013;58(5):241-9.
Mameli G, Erre GL, Caggiu E, Mura S, Cossu D, Bo M, et al. Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study. Clin Exp Immunol. 2017;189(1):127-31.
Krzysztalowska-Wawrzyniak M, Ostanek M, Clark J, Binczak-Kuleta A, Ostanek L, Kaczmarczyk M, et al. The distribution of human endogenous retrovirus K-113 in health and autoimmune diseases in Poland. Rheumatology (Oxford, England). 2011;50(7):1310-4.
Gaudin P, Ijaz S, Tuke PW, Marcel F, Paraz A, Seigneurin JM, et al. Infrequency of detection of particle-associated MSRV/HERV-W RNA in the synovial fluid of patients with rheumatoid arthritis. Rheumatology (Oxford, England). 2000;39(9):950-4.
Ejtehadi HD, Freimanis GL, Ali HA, Bowman S, Alavi A, Axford J, et al. The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study. Annals of the rheumatic diseases. 2006;65(5):612-6.
Takeuchi K, Katsumata K, Ikeda H, Minami M, Wakisaka A, Yoshiki T. Expression of endogenous retroviruses, ERV3 and lambda 4-1, in synovial tissues from patients with rheumatoid arthritis. Clin Exp Immunol. 1995;99(3):338-44.
Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJ, Shattles WG, Clark DA, et al. The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. British journal of rheumatology. 1992;31(11):735-42.
Nakagawa K, Brusic V, McColl G, Harrison LC. Direct evidence for the expression of multiple endogenous retroviruses in the synovial compartment in rheumatoid arthritis. Arthritis and rheumatism. 1997;40(4):627-38.
Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJ. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clin Exp Immunol. 2002;128(1):75-82.
Ramos-Lopez E, Ghebru S, Van Autreve J, Aminkeng F, Herwig J, Seifried E, et al. Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes. Tissue antigens. 2006;68(2):147-52.
Lan M, Mason A, Coutant R, Chen Q-Y, Vargas A, Rao J, et al. HERV-K10s and immune-mediated (type 1) diabetes1998. 14-6; discussion 6 p.
Pani MA, Wood JP, Bieda K, Toenjes RR, Usadel KH, Badenhoop K. The variable endogenous retroviral insertion in the human complement C4 gene: a transmission study in type I diabetes mellitus. Hum Immunol. 2002;63(6):481-4.
Laska MJ, Troldborg A, Hauge EM, Bahrami S, Stengaard-Pedersen K. Human Endogenous Retroviral Genetic Element With Immunosuppressive Activity in Both Human Autoimmune Diseases and Experimental Arthritis. Arthritis & rheumatology (Hoboken, NJ). 2017;69(2):398-409.
Pullmann R, Jr., Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis and rheumatism. 2008;58(2):532-40.
Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis and rheumatism. 1995;38(11):1660-71.
Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, et al. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral immunology. 1997;10(3):137-47.
Bengtsson A, Blomberg J, Nived O, Pipkorn R, Toth L, Sturfel G. Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 1996;39(10):1654-63.
Herve CA, Lugli EB, Brand A, Griffiths DJ, Venables PJW. Autoantibodies to human endogenous retrovirus-K are frequently detected in health and disease and react with multiple epitopes. Clinical and experimental immunology. 2002;128(1):75-82.
Magistrelli C, Samoilova E, K. Agarwal R, Banki K, Ferrante P, Vladutiu A, et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity1999. 829-34 p.
Faucard R, Madeira A, Gehin N, Authier F-J, Panaite P-A, Lesage C, et al. Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. EBioMedicine. 2016;6:190-8.
Perron H, Dougier-Reynaud H-L, Lomparski C, Popa I, Firouzi R, Bertrand J-B, et al. Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. PloS one. 2013;8(12):e80128-e.
Shattles WG, Brookes SM, Venables PJ, Clark DA, Maini RN. Expression of antigen reactive with a monoclonal antibody to HTLV-1 P19 in salivary glands in Sjögren's syndrome. Clinical and experimental immunology. 1992;89(1):46-51.
Moles JP, Tesniere A, Guilhou JJ. A new endogenous retroviral sequence is expressed in skin of patients with psoriasis. The British journal of dermatology. 2005;153(1):83-9.
Lai OY, Chen H, Michaud H-A, Hayashi G, Kuebler PJ, Hultman GK, et al. Protective effect of human endogenous retrovirus K dUTPase variants on psoriasis susceptibility. The Journal of investigative dermatology. 2012;132(7):1833-40.
Pani MA, Seidl C, Bieda K, Seissler J, Krause M, Seifried E, et al. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clinical Endocrinology. 2002;56(6):773-7.
Yao Y, Schroder J, Nellaker C, Bottmer C, Bachmann S, Yolken RH, et al. Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia. Genes, brain, and behavior. 2008;7(1):103-12.
Weis S, Llenos IC, Sabunciyan S, Dulay JR, Isler L, Yolken R, et al. Reduced expression of human endogenous retrovirus (HERV)-W GAG protein in the cingulate gyrus and hippocampus in schizophrenia, bipolar disorder, and depression. Journal of neural transmission (Vienna, Austria : 1996). 2007;114(5):645-55.
Suntsova M, Gogvadze EV, Salozhin S, Gaifullin N, Eroshkin F, Dmitriev SE, et al. Human-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(48):19472-7.
Perron H, Mekaoui L, Bernard C, Veas F, Stefas I, Leboyer M. Endogenous Retrovirus Type W GAG and Envelope Protein Antigenemia in Serum of Schizophrenic Patients. Biological Psychiatry. 2008;64(12):1019-23.
Otowa T, Tochigi M, Rogers M, Umekage T, Kato N, Sasaki T. Insertional polymorphism of endogenous retrovirus HERV-K115 in schizophrenia. Neuroscience Letters. 2006;408(3):226-9.
Mak M, Samochowiec J, Frydecka D, Pelka-Wysiecka J, Szmida E, Karpinski P, et al. First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood. Psychiatry research. 2019;271:459-63.
Karlsson H, Schroder J, Bachmann S, Bottmer C, Yolken RH. HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder. Molecular psychiatry. 2004;9(1):12-3.
Huang W, Li S, Hu Y, Yu H, Luo F, Zhang Q, et al. Implication of the env gene of the human endogenous retrovirus W family in the expression of BDNF and DRD3 and development of recent-onset schizophrenia. Schizophrenia bulletin. 2011;37(5):988-1000.
Dickerson F, Rubalcaba E, Viscidi R, Yang S, Stallings C, Sullens A, et al. Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia. Schizophrenia research. 2008;104(1-3):121-6.
Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, et al. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer immunity. 2008;8:15-.
Agoni L, Guha C, Lenz J. Detection of Human Endogenous Retrovirus K (HERV-K) Transcripts in Human Prostate Cancer Cell Lines. Frontiers in oncology. 2013;3:180-.
Goering W, Schmitt K, Dostert M, Schaal H, Deenen R, Mayer J, et al. Human endogenous retrovirus HERV-K(HML-2) activity in prostate cancer is dominated by a few loci. The Prostate. 2015;75(16):1958-71.
Wang-Johanning F, Frost AR, Jian B, Azerou R, Lu DW, Chen DT, et al. Detecting the expression of human endogenous retrovirus E envelope transcripts in human prostate adenocarcinoma. Cancer. 2003;98(1):187-97.
Argaw-Denboba A, Balestrieri E, Serafino A, Cipriani C, Bucci I, Sorrentino R, et al. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. Journal of experimental & clinical cancer research : CR. 2017;36(1):20.
Huang G, Li Z, Wan X, Wang Y, Dong J. Human endogenous retroviral K element encodes fusogenic activity in melanoma cells. Journal of carcinogenesis. 2013;12:5-.
Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, et al. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS research and human retroviruses. 2008;24(5):717-23.
Oricchio E, Sciamanna I, Beraldi R, Tolstonog GV, Schumann GG, Spadafora C. Distinct roles for LINE-1 and HERV-K retroelements in cell proliferation, differentiation and tumor progression. Oncogene. 2007;26(29):4226-33.
Li Z, Sheng T, Wan X, Liu T, Wu H, Dong J. Expression of HERV-K correlates with status of MEK-ERK and p16INK4A-CDK4 pathways in melanoma cells. Cancer investigation. 2010;28(10):1031-7.
Pothlichet J, Mangeney M, Heidmann T. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int J Cancer. 2006;119(8):1869-77.
Schanab O, Humer J, Gleiss A, Mikula M, Sturlan S, Grunt S, et al. Expression of human endogenous retrovirus K is stimulated by ultraviolet radiation in melanoma. Pigment cell & melanoma research. 2011;24(4):656-65.
Serafino A, Balestrieri E, Pierimarchi P, Matteucci C, Moroni G, Oricchio E, et al. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation. Experimental cell research. 2009;315(5):849-62.
Stengel S, Fiebig U, Kurth R, Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes, chromosomes & cancer. 2010;49(5):401-11.
Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, et al. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clin Cancer Res. 2015;21(2):471-83.
Iramaneerat K, Rattanatunyong P, Khemapech N, Triratanachat S, Mutirangura A. HERV-K hypomethylation in ovarian clear cell carcinoma is associated with a poor prognosis and platinum resistance. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2011;21(1):51-7.
Kahyo T, Tao H, Shinmura K, Yamada H, Mori H, Funai K, et al. Identification and association study with lung cancer for novel insertion polymorphisms of human endogenous retrovirus. Carcinogenesis. 2013;34(11):2531-8.
Li M, Radvanyi L, Yin B, Li J, Chivukula R, Lin K, et al. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(19):5892-911.
Liang Q, Xu Z, Xu R, Wu L, Zheng S. Expression patterns of non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in colon cancer. PloS one. 2012;7(1):e29950-e.
Ma W, Hong Z, Liu H, Chen X, Ding L, Liu Z, et al. Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma. BioMed Research International. 2016;2016:9.
Benešová M, Trejbalová K, Kovářová D, Vernerová Z, Hron T, Kučerová D, et al. DNA hypomethylation and aberrant expression of the human endogenous retrovirus ERVWE1/syncytin-1 in seminomas. Retrovirology. 2017;14(1):20-.
Gosenca D, Gabriel U, Steidler A, Mayer J, Diem O, Erben P, et al. HERV-E-Mediated Modulation of PLA2G4A Transcription in Urothelial Carcinoma. PLOS ONE. 2012;7(11):e49341.
- Abstract Viewed: 156 times
- PDF Downloaded: 84 times